Patent AnalyticsExaminers
Rankings

Company or institution

REMYND NV

16 applicationsfiled 2008 to 2025

Allowance rate
73%
−2 pts vs the USPTO range 48% to 89%
Rejections before allowance
2.4
+0.8 vs the USPTO
Months to first action
8.1 mo
−10.5 vs the USPTO
Needed an RCE
53%
+26 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations8 apps
C07D Heterocyclic compounds5 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids1 apps
G01N Investigating or analysing materials1 apps
A61P Therapeutic activity of compounds1 apps

Art units

16245 apps
16264 apps
16282 apps
16991 apps
16361 apps
16561 apps

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19585249MODULATORS OF SEPTIN 6 FOR USE IN THE PREVENTION AND/OR TREATMENT OF NEURODEGENERAT…2026-05-06Pending00n/a
19585072TRIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS2026-05-06Pending00n/a
18881472(AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS2025-01-06Pending0020.6 mo
15802616Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15754522Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15461028Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15333892Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15460798Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15459410Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15532623Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 16 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in